Austin Health

Title
The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile.
Publication Date
2021
Author(s)
Berthelet, Jean
Wimmer, Verena C
Whitfield, Holly J
Serrano, Antonin
Boudier, Thomas
Mangiola, Stefano
Merdas, Michal
El-Saafin, Farrah
Baloyan, David
Wilcox, Jordan
Wilcox, Steven
Parslow, Adam C
Papenfuss, Anthony T
Yeo, Belinda
Ernst, Matthias
Pal, Bhupinder
Anderson, Robin L
Davis, Melissa J
Rogers, Kelly L
Hollande, Frédéric
Merino, Delphine
Type of document
Journal Article
OrcId
0000-0003-2562-0575
0000-0002-9931-8179
0000-0002-7282-387X
0000-0002-8178-6441
0000-0002-0148-7733
0000-0001-7474-836X
0000-0003-3257-9953
0000-0002-1650-8007
0000-0002-0585-9573
0000-0002-9868-6914
0000-0002-1102-8506
0000-0002-9218-9917
0000-0003-4864-7033
0000-0002-6755-0221
0000-0002-7046-8392
0000-0002-8075-6275
DOI
10.1126/sciadv.abf4408
Abstract
Intratumoral heterogeneity is a driver of breast cancer progression, but the nature of the clonal interactive network involved in this process remains unclear. Here, we optimized the use of optical barcoding to visualize and characterize 31 cancer subclones in vivo. By mapping the clonal composition of thousands of metastases in two clinically relevant sites, the lungs and liver, we found that metastases were highly polyclonal in lungs but not in the liver. Furthermore, the transcriptome of the subclones varied according to their metastatic niche. We also identified a reversible niche-driven signature that was conserved in lung and liver metastases collected during patient autopsies. Among this signature, we found that the tumor necrosis factor-α pathway was up-regulated in lung compared to liver metastases, and inhibition of this pathway affected metastasis diversity. These results highlight that the cellular and molecular heterogeneity observed in metastases is largely dictated by the tumor microenvironment.
Link
Citation
Science advances 2021; 7(28)
Jornal Title
Science Advances

Files:

NameSizeformatDescriptionLink